Search
With a 20-year history supporting CMS with such complex legislative changes as the Affordable Care Act, Medicare Access and CHIP Reauthorization Act, and Medicare Modernization Act, Guidehouse is a trusted partner with supporting policy decisions and promoting innovation. We also bring relevant experience across the health ecosystem, from Food and Drug Administration drug development to federal and commercial pharmacy operations and regulatory compliance. Our integrated public and commercial sector strategy, change management, IT and analytics, clinical, and program transformation experts help federal health agencies achieve their missions and sustainable success.
It is important to consider risks and unintended consequences associated with developing and operationalizing policies and procedures and establishing monitoring and reporting processes. Some specific considerations for drug price negotiation include:
Listen to Lessons Learned from Relevant Experiences:
Guidehouse is a global consultancy providing advisory, digital, and managed services to the commercial and public sectors. Purpose-built to serve the national security, financial services, healthcare, energy, and infrastructure industries, the firm collaborates with leaders to outwit complexity and achieve transformational changes that meaningfully shape the future.